Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington
In 1995, Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington’s (UW) School…
In 1995, Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington’s (UW) School…
On Oct. 7, 1994, a strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and…
In 1994, the National Violence against Women Survey was created by the U.S. Centers for Disease Control and…
On Jun. 10, 1993, the U.S. Congress signed the National Institutes of Health Revitalization Act, P.L. 103-43. The…
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress….
On Oct. 7, 1992, all U.S. mammography facilities, except those managed by the Department of Veterans Affairs, must…
In 1991, the U.S. Centers for Disease Control and Prevention (CDC) began developing a national strategic plan for…
In 1991, the Women’s Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was…
In 1990, Geneticist Mary-Claire King and her colleagues at the University of California, Berkeley discovered BRCA1, the first…
In 1989, Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells….
In 1989, the State Office of Rural Health became part of Oregon Health & Science University (OHSU) to…
In December 1988, the National Cancer Institute (NCI) sponsored a workshop to address the standardization of cervical/vaginal cytopathology…
In 1985, Lumpectomy plus radiation therapy was found equivalent to mastectomy for early breast cancer. Lumpectomy followed by…
In 1985, the HER2 oncogene was discovered by Axel Ullrich, a young scientist at Genentech. The new oncogene…
In 1983, The Meyer L. Prentis Comprehensive Cancer Center of Metropolitan Detroit now known as the Karmanos Cancer…
In 1982, the WISEST (Women in Scholarship, Engineering, Science & Technology) began at the University of Alberta when…
In May 1980, the U.S. Centers for Disease Control and Prevention (CDC) organized a task force to study…
In 1980, three of Boston’s oldest and most prestigious Harvard Medical School teaching hospitals – the Peter Bent…
In 1979, Modified radical mastectomy replaced radical mastectomy for breast cancer. The standard of care for patients with…
On Dec. 30, 1977, the U.S. Food and Drug Administration approved Tamoxifen, an anti-estrogen drug, for the treatment…
On May 12, 1977, the Program for the Introduction and Adaptation of Contraceptive Technology (PIACT) was founded by…
In 1977, Dr. Henry Friesen of McGill University discovered the hormone prolactin and defined its role as a…
In 1976, Albert Einstein Cancer Center researchers identified the mechanism of action of Taxol, one of the most…
In 1974, the National Cancer Institute (NCI) chose the Pacific Health Research Institute (PHRI) to undertake the ‘Breast…
In 1973, clinicians at the Boston Hospital for Women, now part of Brigham and Womenï¾’s, developed noninvasive fetal…
In 1967, the construction of the Salk Institute for Biological Studies was completed. the original Institute buildings were…
In 1963, The Health Insurance Plan (HIP) of Greater New York Study began. HIP was the first randomized…
In 1960, the U.S. Surgeon General, in response to substantial morbidity and mortality during the 1957-58 pandemic, recommends…
In 1945, W. Ray Bryan, Michael B. Shimkin, Howard B. Andervont, Herbert Kahler and Thelma B. Dunn published…